CareTrust REIT (CTRE) Q2 Revenue Up 63%

CareTrust REIT (CTRE) reported strong Q2 FY2025 results, significantly surpassing analyst estimates with GAAP revenue of $112.469 million and normalized FFO per share of $0.43, representing 63.3% and 19.4% year-over-year growth, respectively. This performance was largely driven by its largest-ever acquisition of Care REIT plc, which marked CTRE's entry into the U.K. market and diversified its portfolio away from U.S. skilled nursing. While management raised FY2025 guidance reflecting the expanded portfolio, investors should note the substantial increase in general and administrative expenses and the share dilution resulting from equity sales used to finance the expansion.

Analysis

CareTrust REIT (CTRE) reported a significantly strong second quarter for FY2025, driven by its transformative acquisition of Care REIT plc. The company substantially beat analyst expectations with GAAP revenue of $112.47 million, a 63.3% year-over-year increase, and normalized Funds From Operations (FFO) of $0.43 per share, which was 19.4% higher than the prior year and well above the $0.34 consensus estimate. This performance was underpinned by the company's largest-ever acquisition, which marked its entry into the U.K. market and strategically reduced its U.S. skilled nursing facility concentration to approximately 63% of rental income. Despite the strong top-line and FFO growth, the expansion came at the cost of significant share dilution, with share count increasing 32.7% year-over-year to fund the $1.1 billion in investment activity. Furthermore, general and administrative expenses doubled compared to Q2 2024, a metric that warrants monitoring. Management expressed confidence by raising full-year 2025 guidance for FFO per share to a range of $1.77 to $1.79 and increasing the quarterly dividend by 15.5% to $0.335 per share, signaling a positive outlook on the newly expanded portfolio's cash flow generation capabilities.

Key Decisions for Investors

• The strong earnings beat, raised full-year guidance, and a 15.5% dividend increase affirm the accretive nature of the recent U.K. acquisition, supporting a bullish outlook on the company's growth strategy.
• Investors should closely monitor the integration of the U.K. portfolio and track general and administrative expenses, as disciplined cost control will be critical to realizing the full long-term value of the expansion.
• While growth is robust, the 32.7% year-over-year increase in share count is a significant dilution factor, making it essential to evaluate the company's future financing strategy and its impact on per-share returns.
• The combination of strong operational fundamentals, including 99.7% rent collection, and strategic diversification away from U.S. skilled nursing may warrant a re-evaluation of the company's risk profile and long-term potential.